| __timestamp | Alkermes plc | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 7753000 | 242549000 |
| Thursday, January 1, 2015 | 4019000 | 245098000 |
| Friday, January 1, 2016 | 2301000 | 147600000 |
| Sunday, January 1, 2017 | 7232000 | 264600000 |
| Monday, January 1, 2018 | 68895000 | 357900000 |
| Tuesday, January 1, 2019 | 52816000 | 1182600000 |
| Wednesday, January 1, 2020 | 1946000 | 357700000 |
| Friday, January 1, 2021 | 1020000 | 540100000 |
| Saturday, January 1, 2022 | 393842000 | 322900000 |
| Sunday, January 1, 2023 | 270806000 | 408000000 |
| Monday, January 1, 2024 | 245326000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, United Therapeutics Corporation and Alkermes plc have showcased contrasting strategies in their R&D investments. From 2014 to 2023, United Therapeutics consistently outpaced Alkermes, with R&D expenses peaking in 2019 at nearly 1.2 billion, a staggering 400% more than Alkermes' highest expenditure in 2022. This trend highlights United Therapeutics' aggressive pursuit of breakthroughs, while Alkermes' spending, though more modest, saw a significant surge in recent years, culminating in a 2022 peak. The data reveals a strategic shift for Alkermes, possibly indicating a renewed focus on innovation. As these companies continue to navigate the evolving pharmaceutical landscape, their R&D investments will be crucial in determining their future success.
Analyzing R&D Budgets: Sanofi vs United Therapeutics Corporation
Gilead Sciences, Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs United Therapeutics Corporation
Regeneron Pharmaceuticals, Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Apellis Pharmaceuticals, Inc.
Analyzing R&D Budgets: United Therapeutics Corporation vs MorphoSys AG
United Therapeutics Corporation or Vericel Corporation: Who Invests More in Innovation?
United Therapeutics Corporation or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
R&D Insights: How Jazz Pharmaceuticals plc and Alkermes plc Allocate Funds
Research and Development Investment: Alkermes plc vs Opthea Limited
Alkermes plc or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Alkermes plc vs Agios Pharmaceuticals, Inc.